Literature DB >> 17368499

Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.

Lawrence M Mylin1, Todd D Schell, Melanie Epler, Caroline Kusuma, David Assis, Chelsea Matsko, Alexandra Smith, April Allebach, Satvir S Tevethia.   

Abstract

To better understand the relationship between epitope variation and tumor escape from immune surveillance, SV40 T antigen-transformed B6/K-0 cells were subjected to selection with individual CTL clones specific for the SV40 T antigen H-2D(b)-restricted epitopes I or V. CTL-resistant populations were isolated from a majority of the selection cultures and substituted epitope sequences were identified within most of the resistant populations. Tag sequences deleted of all or portions of the selection-targeted epitope were identified, but in lower numbers compared to epitope sequences bearing single residue substitutions. Relatively few flanking residue substitutions were identified, and only in epitope I-targeted selections. The diversity (numbers and epitope residue locations) of substituted epitope residue positions varied between selections. These findings suggest that the scope of spontaneously occurring mutations that could allow for escape from individual CD8+ T cell clones is large.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368499      PMCID: PMC3866617          DOI: 10.1016/j.virol.2007.02.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  64 in total

1.  Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.

Authors:  N Shastri; T Serwold; F Gonzalez
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

2.  Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations.

Authors:  T D Kierstead; M J Tevethia
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

3.  Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Authors:  L M Mylin; R H Bonneau; J D Lippolis; S S Tevethia
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.

Authors:  A C Young; W Zhang; J C Sacchettini; S G Nathenson
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

5.  In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes.

Authors:  L Wiesmüller; J Cammenga; W W Deppert
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 6.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.

Authors:  J D Lippolis; L M Mylin; D T Simmons; S S Tevethia
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.

Authors:  M E Dudley; D C Roopenian
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 10.  Human tumor antigens recognized by T lymphocytes.

Authors:  T Boon; P van der Bruggen
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  2 in total

1.  Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.

Authors:  Kathleen Anders; Christian Buschow; Andreas Herrmann; Ana Milojkovic; Christoph Loddenkemper; Thomas Kammertoens; Peter Daniel; Hua Yu; Jehad Charo; Thomas Blankenstein
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

2.  Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells.

Authors:  Alan M Watson; Lawrence M Mylin; Megan M Thompson; Todd D Schell
Journal:  J Immunol       Date:  2012-11-21       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.